The Effect of Curcumin on Renal Ischemia/Reperfusion Injury in Diabetic Rats.
Douglas Ikedo MachadoEloiza de Oliveira SilvaSara VenturaMaria de Fatima Fernandes VattimoPublished in: Nutrients (2022)
Chronic kidney disease (CKD) and acute kidney injury (AKI) are global health problems that affect over 850 million people, twice the number of diabetic individuals around the world. Diabetes mellitus (DM) is known to increase the susceptibility to AKI. Plants and foods, such as curcumin, are traditionally used as treatments for various diseases due to its wide range of bioactive compounds that exert antioxidative, anti-inflammatory, antimicrobial and anticancer properties. The aim of this study is to evaluate the effect of curcumin in diabetic rats with AKI. Adult male Wistar rats, weighing between 250 and 290 g, were randomized into four groups: Citrate (citrate buffer, i.v., single dose, on Day 1 of the protocol); DM (streptozotocin (STZ), 65 mg/k, single dose, i.v., on Day 1); DM + I/R (DM rats that, on Day 26, had the renal pedicle clamped for 30 min on both sides); DM + I/R + Curcumin (DM + I/R rats submitted to curcumin treatment). Results showed that IR worsened renal function and oxidative stress in DM rats, but the DM + IR + Curcumin group showed an increase in inulin clearance and a decrease in serum creatinine and in NGAL, in addition to an improvement in renal hemodynamics. These effects were accompanied by a reduction in oxidative and nitrosative metabolites and an increase in the thiol antioxidant reserve when curcumin was administered to the DM + IR group.
Keyphrases
- diabetic rats
- oxidative stress
- acute kidney injury
- glycemic control
- chronic kidney disease
- anti inflammatory
- global health
- type diabetes
- cardiac surgery
- dna damage
- ischemia reperfusion injury
- mental health
- clinical trial
- end stage renal disease
- weight loss
- double blind
- young adults
- endoplasmic reticulum stress
- replacement therapy
- placebo controlled